Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TORAVA: Torisel and Avastin in First-line Metastatic Renal Cell Carcinoma
NCT00619268Phase 2Completed
- Sponsor
- Centre Léon Bérard
- Start
- Feb 2008
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temsirolimus in metastatic renal cell carcinoma (mRCC), sponsored by Centre Léon Bérard. Started Feb 2008; status: completed.
02
Drugs
temsirolimus
03
Conditions
metastatic renal cell carcinoma (mRCC)
Beyond the preview
Go deeper on NCT00619268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00619268.